Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析

◆英語タイトル:Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82922FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Medicamen Biotech Ltd (531146) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Medicamen Biotech Ltd (Medicamen) is a pharmaceutical company that manufactures and markets generic pharmaceutical formulations for the domestic and international markets. It manufactures and supplies range of products including tablets; dry syrups; capsules and liquid syrups (beta lactum and non-beta lactum); ointments; oral rehydration salts (ORS) and creams. The company has agreements with pharmaceutical distributors and importers in Africa, Central America/South America, Brazil, CIS and South East Asia. The company has manufacturing facilities in Bhiwadi, Rajasthan and Haridwar, Uttarakhand which are certified with ISO 9001:2000 and WHO-GMP. Medicamen is headquartered in New Delhi, India.

Medicamen Biotech Ltd Key Recent Developments

Jan 29,2020: Medicamen Biotech announces Resignation of director
Feb 11,2019: Medicamen Biotech announces appointment of director
Jan 24,2019: Medicamen Biotech names Mr. Rajesh Kumar Chauhan as Whole Time Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Medicamen Biotech Ltd – Key Facts
Medicamen Biotech Ltd – Key Employees
Medicamen Biotech Ltd – Key Employee Biographies
Medicamen Biotech Ltd – Major Products and Services
Medicamen Biotech Ltd – History
Medicamen Biotech Ltd – Company Statement
Medicamen Biotech Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Medicamen Biotech Ltd – Business Description
Medicamen Biotech Ltd – SWOT Analysis
SWOT Analysis – Overview
Medicamen Biotech Ltd – Strengths
Medicamen Biotech Ltd – Weaknesses
Medicamen Biotech Ltd – Opportunities
Medicamen Biotech Ltd – Threats
Medicamen Biotech Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Medicamen Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Medicamen Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Medicamen Biotech Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 29, 2020: Medicamen Biotech announces Resignation of director
Feb 11, 2019: Medicamen Biotech announces appointment of director
Jan 24, 2019: Medicamen Biotech names Mr. Rajesh Kumar Chauhan as Whole Time Director
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Medicamen Biotech Ltd, Key Facts
Medicamen Biotech Ltd, Key Employees
Medicamen Biotech Ltd, Key Employee Biographies
Medicamen Biotech Ltd, Major Products and Services
Medicamen Biotech Ltd, History
Medicamen Biotech Ltd, Other Locations
Medicamen Biotech Ltd, Subsidiaries
Medicamen Biotech Ltd, Key Competitors
Medicamen Biotech Ltd, Ratios based on current share price
Medicamen Biotech Ltd, Annual Ratios
Medicamen Biotech Ltd, Annual Ratios (Cont...1)
Medicamen Biotech Ltd, Annual Ratios (Cont...2)
Medicamen Biotech Ltd, Interim Ratios
Medicamen Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Medicamen Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Medicamen Biotech Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • U-Haul International, Inc.:企業の戦略的SWOT分析
    U-Haul International, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Baltika Breweries LLC:戦略・SWOT・企業財務分析
    Baltika Breweries LLC - Strategy, SWOT and Corporate Finance Report Summary Baltika Breweries LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Massachusetts General Hospital-医療機器分野:企業M&A・提携分析
    Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers diagnostic and therapeutic care services. The hospital provides services such as allergy and immunology; ALS multidisciplinary clinic, anesthesia, critical care and pain medicine; back bay healthcare center, b …
  • MVV Energie AG:企業の戦略・SWOT・財務情報
    MVV Energie AG - Strategy, SWOT and Corporate Finance Report Summary MVV Energie AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • HD Supply Inc:企業の戦略的SWOT分析
    HD Supply Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • ContraFect Corp (CFRX):企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) operates as a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious …
  • Taragenyx Ltd:企業の製品パイプライン分析2018
    Summary Taragenyx Ltd (Taragenyx) is a medical technology company that provides regenerative medicine technology, medical and biological engineering solutions. The company offers restorative implant solutions generation, burdensome operations, and medical, orthopaedic, dental implantation solutions, …
  • Inhibrx LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The company’s products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. I …
  • Delphi Financial Group, Inc.:企業の戦略・SWOT・財務情報
    Delphi Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Delphi Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Titan Medical Inc (TMD)-医療機器分野:企業M&A・提携分析
    Summary Titan Medical Inc (Titan) is a development stage company that designs and develops a robotic surgical system for application in minimally invasive surgery (MIS). The company's lead product candidate, single port robotic (SPORT) surgical system is a single-incision robotic surgical system tha …
  • Beijing Beilu Pharmaceutical Co Ltd (300016):製薬・医療:M&Aディール及び事業提携情報
    Summary Beijing Beilu Pharmaceutical Co Ltd (Beijing BeiLu) is a manufacturer of traditional Chinese medicine preparation and psychiatric products. The company provides product portfolio such as contrast media products, anti anxiety medicines and oral antihyperglycemic agents, among others. Its cont …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • McDonald’s Australia Limited:企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Suning.com Co., Ltd. (002024):企業の財務・戦略的SWOT分析
    Suning.com Co., Ltd. (002024) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Partners HealthCare System Inc:企業の戦略的SWOT分析
    Partners HealthCare System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Tecumseh Products Company:企業の戦略的SWOT分析
    Tecumseh Products Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Modus Therapeutics Holding AB-製薬・医療分野:企業M&A・提携分析
    Summary Modus Therapeutics Holding AB (Modus), formerly known as Dilaforette Holding AB, is a biotechnology company that focuses on the development of sevuparin, a proprietary polysaccharide drug for the treatment of sickle cell disease (SCD). Modus Therapeutics Holding AB - Pharmaceuticals & Health …
  • PCI Pharma Services-製薬・医療分野:企業M&A・提携分析
    Summary PCI Pharma Services (PCI) is a drug development company that offers clinical manufacturing and packaging solutions. The company offers clinical services such as pharmaceutical development, clinical trial manufacturing, clinical trial packaging, clinical supplies management, clinical planning …
  • Metsa Board Corporation:企業のM&A・事業提携・投資動向
    Metsa Board Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Metsa Board Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Bionomics Ltd (BNO)-製薬・医療分野:企業M&A・提携分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that focuses on the development of treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. Its pipeline products include BNC210, BNC 105, BNC101, and BNC375. The company uses var …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆